OncoMed Pharmaceuticals Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
OncoMed Pharmaceuticals Inc had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $603.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2018-03-09
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $603.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2017-12-31 | $603.00K 10-K · filed 2018-03-09 |